Reduced efficacy of topical corticosteroid in preventing cytarabine-induced kerato-conjunctivitis in patients receiving high-dose cytarabine and total body irradiation for allogeneic hematopoietic stem cell transplantation

Bone Marrow Transplantation

Volumn 42, Issue 3, 2008, Pages 197-199

  Mori, T ^a   Watanabe, M ^b   Kurotori Sotome, T ^b   Ito, C ^b   Yamada, K ^b   Yashima, T ^b   Kobayashi, N ^b   Kondo, S ^b   Aisa, Y ^a   Kato, J ^a   Ogawa, Y ^a   Tsubota, K ^a   Shigematsu, N ^a   Kubo, A ^a   Ikeda, Y ^a   Okamoto, S ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KEIO UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL TEAR; BETAMETHASONE SODIUM PHOSPHATE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYTARABINE; EYE DROPS; HYALURONIC ACID;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; HEMATOLOGIC MALIGNANCY; HUMAN; INCIDENCE; KERATOCONJUNCTIVITIS; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SYMPTOM; TREATMENT DURATION; WHOLE BODY RADIATION;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; CYTARABINE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; KERATOCONJUNCTIVITIS; LEUKEMIA; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; WHOLE-BODY IRRADIATION;

EID: 50049105747     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2008.152     Document Type: Article

References (13)

1. Herzig RH, Wolff SN, Lazarus HM, Phillips GL, Karanes C. Herzig GP. High-dose cytosine arabinoside therapy for refractory leukemia. Blood 1983; 62: 361-369.
2. Al-Tweigeri T, Nabholtz JM, Mackey JR. Ocular toxicity and cancer chemotheraphy. Cancer 1996; 78: 1359-1373.
3. Lass JH, Lazarus HM, Reed MD. Herzig RH. Topical corticosteroid therapy for corneal toxicity from systemically administered cytarabine. Am J Ophthalmol 1982; 94: 617-621.
4. Coccia PF, Strandjord SE, Warkentin PI, Cheung NK, Gordon EM, Novak LJ et al. High-dose cytosine arabinoside and fractionated total-body irradiation: An improved preparative regimen for bone marrow transplantation of children with acute lymphoblastic leukemia in remission. Blood 1988; 71: 888-893.
5. Riddell S, Appelbaum FR, Buckner CD, Stewart P, Clift R, Sanders J et al. High-dose cytarabine and total body irradiation with or without cyclophosphamide as a preparative regimen for marrow transplantation for acute leukemia. J Clin Oncol 1988; 6: 576-582.
6. Kamani N, Bayever E, August CS, Bunin N, Goldwein JW, D'Angio GJ. Fractionated total-body irradiation preceding high-dose cytosine arabinoside as a preparative regimen for bone marrow transplantation in children with acute leukemia. Med Pediatr Oncol 1995; 25: 179-184.
7. Takahashi S, Okamoto S-I, Shirafuji N, Ikebuchi K, Tani K, Shimane M et al. Recombinant human glycosylated granulocyte colony-stimulating factor (rhG-CSF)-combined regimen for allogeneic bone marrow transplantation in refractory acute myeloid leukemia. Bone Marrow Transplant 1994; 13:239-245.
8. Okamoto S, Takahashi S, Wakui M, Ishida A, Tanosaki R, Ikeda Y et al. Treatment of advanced myelodysplastic syndrome with a regimen including recombinant human granulocyte colony-stimulating factor preceding allogeneic bone marrow transplantation. Br J Haematol 1999; 104: 569-573.
9. Mori T, Aisa Y, Yokoyama A, Nakazato T, Yamazaki R, Shimizu T et al. Total body irridiation and granulocyte colony-stimulating factor-combined high-dose cytarabine as a conditioning regimen in allogeneic hematopoietic stem cell transplantation for advanced myelodysplastic syndrome: A single-institute experience. Bone Marrow Transplant 2007; 39: 217-221.
10. Bessell EM, Henk JM, Whitelocke RA, Wright JE. Ocular morbidity after radiotherapy of orbital and conjunctival lymphoma. Eye 1987; 1 90-96.
11. Letschert JG, González González D, Oskam J, Koornneef L, van Dijk JD, Boukes R et al. Results of radiotherapy in patients with stage 1 orbital non-Hodgkin's lymphoma. Radiother Oncol 1991; 22: 36-44.
12. Lazarus HM, Hartnett ME, Reed MD, Murphy BF, Lass JH. Comparison of the prophylactic effects of 2-deoxycytidine and prednisolone for high-dose intravenous cytarabine-induced keratilis. Am J Ophthalmol 1987; 104: 476-480.
13. Higa GM, Gockerman JP, Hunt AL, Jones MR, Horne BJ. The use of prophylactic eye drops during high-dose cytosine arabinoside therapy. Cancer 1991; 68: 1691-1693.